e-learning
resources
Munich 2006
Sunday 03.09.2006
Molecular airway biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring
V. Sorbello, B. Pergolizzi, A. Sillo, S. Bozzaro, V. De Rose (Orbassano, Italy)
Source:
Annual Congress 2006 - Molecular airway biology
Session:
Molecular airway biology
Session type:
Oral Presentation
Number:
954
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Sorbello, B. Pergolizzi, A. Sillo, S. Bozzaro, V. De Rose (Orbassano, Italy). Proteomic analysis of sputum from adults with cystic fibrosis and COPD: identification of potential biomarkers for disease monitoring. Eur Respir J 2006; 28: Suppl. 50, 954
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
The physiology of breathlessness
Related content which might interest you:
SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis
Source: Eur Respir J 2016; 48: 1612-1621
Year: 2016
New proteomic biomarkers of cystic fibrosis: a comparison with non-CF bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
Application of omics technologies to the identification of biomarkers for COPD
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007
Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Comparison of EBC biomarkers in cystic fibrosis and bacterial pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Proteomic derived biomarkers for COPD are present in induced sputum
Source: Eur Respir J 2005; 26: Suppl. 49, 439s
Year: 2005
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
Usefulness of a panel of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes
Source: Eur Respir J, 55 (4) 2000105; 10.1183/13993003.00105-2020
Year: 2020
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Early determinants of lung disease in children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Comparative analysis of multiple gene polymorphisms for acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
The use of non-invasive inflammatory markers to predict presence, severity and stability of cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 327s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept